base-metals-investing Longevity Biotech Stocks Surge as $27 Trillion Healthcare Shift Favors Cell Restoration
base-metals-investing Longevity Biotech Stocks Surge as $27 Trillion Healthcare Shift Favors Cell Restoration
base-metals-investing Lineage Takes Delivery of Gene-edited Hypoimmune Cell Line Under Partnership With Factor Bioscience
base-metals-investing Lineage Cell Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025
base-metals-investing Lineage Announces Research Collaboration With William Demant Invest to Develop ReSonance for Hearing Loss
base-metals-investing Lineage Cell Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
base-metals-investing OpRegen® Phase 1/2a Clinical Study 24-Month Visual Acuity Results Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit
base-metals-investing Lineage Cell Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024
base-metals-investing Lineage Cell Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024
Eagle Energy Metals Corp. and Spring Valley Acquisition Corp. II Announce Effectiveness of Registration Statement and Record and Meeting Dates for Extraordinary General Meeting of Shareholders to Approve Proposed Business Combination
